High Sugar Intake Worsens Antibiotic Damage to Gut Bacteria, Major Study Finds

Sugar Amplifies Antibiotic's Microbial Damage

A large-scale study involving nearly 9,400 monitored meals has revealed that consuming high levels of sugar while taking antibiotics significantly worsens the disruption these drugs cause to beneficial gut bacteria. Researchers from NYU Langone Health, City of Hope, and Memorial Sloan Kettering tracked hospitalized cancer patients and found that for every additional 100 grams of sugar consumed during the 48 hours before antibiotic treatment, there was a measurable 21% decline in alpha diversity—a key measure of bacterial species variety in the gut. The research, published in Nature on September 30, suggests that dietary choices during antibiotic courses could have meaningful health consequences.

The study focused on blood cancer patients undergoing intensive treatments like stem cell transplants, who are frequently hospitalized for weeks while receiving both chemotherapy and antibiotics. This population offered researchers an ideal setting to conduct what became one of the most detailed investigations of its kind, with precise daily records of food consumption and microbiome samples collected throughout treatment periods. The controlled hospital environment allowed researchers to track the exact intake of every meal consumed by 173 patients while monitoring the resulting changes in their gut ecosystems.

Dangerous Bacteria Proliferates Under Sugar and Antibiotics

When antibiotics eliminate large portions of the gut microbiome, the surviving pathogenic bacteria can capitalize on available resources—particularly dietary sugars—to rapidly expand. The research identified Enterococcus faecium as a particular concern, a bacterial species associated with difficult-to-treat infections that flourished when patients combined antibiotic treatment with high sugar consumption. In mouse experiments, animals exposed to the antibiotic biapenem while consuming dietary sucrose experienced a staggering 16.3-fold increase in gut Enterococcus populations by day three, escalating to a 33.4-fold increase by day six.

The mechanism appears to work through a problematic dynamic: antibiotics kill both harmful and beneficial bacteria indiscriminately, reducing microbial diversity and destabilizing the ecosystem. A diverse microbiome normally resists colonization by pathogenic species, but once that diversity is compromised, potentially dangerous bacteria gain unopposed access to nutrients. When dietary sugar is present during this vulnerable period, these surviving pathogens can exploit the readily available energy source to expand their populations before beneficial bacteria can recover and reestablish balance.

Clinical Implications for Cancer Care

For blood cancer patients specifically, the health stakes are particularly high. Microbiome injury from antibiotics has been linked to worse clinical outcomes, including higher overall mortality and increased infection rates. During intensive cancer treatments requiring extended hospitalization, both the patient's diet and gut bacteria undergo dramatic changes simultaneously, creating conditions where microbial disruption can compound other treatment complications. Researchers emphasize that these findings suggest simple dietary modifications—specifically reducing sugar intake during and after antibiotic courses—could potentially improve patient outcomes, though clinical trials testing this hypothesis remain necessary.

The implications extend beyond cancer care. Since antibiotics are among the most widely prescribed medications globally, and antibiotic-induced microbiome disruption has been linked to various long-term health problems, identifying dietary factors that minimize this collateral damage could benefit general populations receiving antibiotic treatment. The researchers note that while the study provides strong correlative evidence, the exact biological mechanisms remain incompletely understood—whether sugar directly fuels Enterococcus growth, weakens competing beneficial bacteria, or operates through alternative pathways requires further investigation.

Path Forward and Research Limitations

The research team emphasizes that while findings strongly suggest reducing simple sugars during antibiotic treatment could limit microbiome injury, considerable work remains before recommending broad dietary interventions to patients. The study's strength lies in its unprecedented scale and detail—over 9,000 recorded meals with daily biological sampling—but researchers caution that more mechanistic studies and clinical trials are needed to definitively establish whether dietary changes translate to improved patient outcomes. The next phase of research should test whether short-term dietary modifications during antibiotic courses actually improve clinical results in hospitalized patients.

The discovery highlights how everyday lifestyle factors, often overlooked in clinical contexts, can significantly influence the delicate balance of gut microbiota during medical treatment. For patients receiving antibiotics, particularly those undergoing intensive cancer therapies, the timing and composition of meals may prove as clinically relevant as the antibiotics themselves.